Nutraceutical Strategies for Blood Pressure Control: Mechanisms, Evidence, and Clinical Implications
Nutraceuticals · 28.05.2026 · 6 (2) · 36
DOI: 10.3390/nutraceuticals6020036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutraceuticals, online erschienen am 28.05.2026. Verfasst von Tea Vrcelj und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hypertension frequently remains uncontrolled despite pharmacological therapy, supporting interest in complementary nutritional strategies. This narrative review evaluates human clinical evidence and mechanistic pathways for minerals, polyphenols, omega-3 fatty acids, probiotics, coenzyme Q10, and L-arginine in blood pressure regulation. Across these categories, antihypertensive effects appear to depend largely on post-ingestion metabolic biotransformation into bioactive metabolites that influence endothelial nitric oxide availability, vascular inflammation, renal sodium handling, and renin–angiotensin system activity. Randomized controlled trials and meta-analyses consistently demonstrate modest reductions in systolic blood pressure of approximately 2–8 mmHg, although most studies are short-term and frequently use supplementation models. The overall certainty of evidence is moderate due to consistent but heterogeneous randomized trials. Variability in response is partly explained by metabolic phenotype and gut microbiota composition, and combined dietary patterns targeting multiple mechanisms may produce additive effects. Overall, nutraceuticals function as adjunct physiological modulators that may contribute to cardiovascular risk reduction but are not intended to replace pharmacological therapy. The present review integrates post-ingestion metabolism, microbiota-derived mediators, and clinical trial evidence into a unified physiological framework explaining why consistent but modest blood pressure reductions occur across heterogeneous interventions. Nutritional strategies remain underutilized in routine clinical practice despite reproducible physiological effects. Incorporating evidence-based nutraceutical approaches alongside pharmacological management may facilitate patient engagement with lifestyle modification, as dietary interventions are often perceived as more achievable than isolated behavioral recommendations. A holistic management model integrating medical therapy, nutrition, and patient education may therefore enhance long-term adherence to cardiovascular prevention strategies and support sustained risk reduction.
Zitieren
APA
Vrcelj, T., Služek, V. B., Kiš, M. F., Waisundara, V. Y., & Banjari, I. (2026). Nutraceutical Strategies for Blood Pressure Control: Mechanisms, Evidence, and Clinical Implications. Nutraceuticals, 6(2), 36. https://doi.org/10.3390/nutraceuticals6020036
Vancouver
Vrcelj T, Služek VB, Kiš MF, Waisundara VY, Banjari I. Nutraceutical Strategies for Blood Pressure Control: Mechanisms, Evidence, and Clinical Implications. Nutraceuticals. 2026;6(2):36. doi:10.3390/nutraceuticals6020036
BibTeX
@article{Vrcelj2026,
author = {Vrcelj, Tea and Služek, Vlatka Buzjak and Kiš, Marina Ferenac and Waisundara, Viduranga Y. and Banjari, Ines},
title = {Nutraceutical Strategies for Blood Pressure Control: Mechanisms, Evidence, and Clinical Implications},
journal = {Nutraceuticals},
year = {2026},
volume = {6},
number = {2},
pages = {36},
doi = {10.3390/nutraceuticals6020036}
}
EUVIMED